Dr Carolyn Taylor
Letters after your name
Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and researcher into the late effects of cancer treatments. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She now continues to research the late effects of cancer treatments and works in the clinic with childhood cancer survivors.
Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials.
Early Breast Cancer Trialists’ Collaborative group (EBCTCG) None., (2021), Lancet Oncol, 22, 1139 - 1150
Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: Cohort study of 2 million women from 57 cancer registries in 22 countries.
Henson KE. et al, (2020), Int J Cancer
Heart failure after treatment for breast cancer
Taylor C. and DARBY S., (2019), European Journal of Heart Failure
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452